85 related articles for article (PubMed ID: 9285573)
1. Public-sector patents on human DNA.
Thomas SM; Birtwistle N; Brady M; Burke JF
Nature; 1997 Aug; 388(6644):709. PubMed ID: 9285573
[No Abstract] [Full Text] [Related]
2. Patients and patents.
Cho MK; Merz JF
Nature; 1997 Nov; 390(6657):221. PubMed ID: 9384365
[No Abstract] [Full Text] [Related]
3. Are human genes patentable?
Sampson MJ
Hastings Cent Rep; 2000; 30(4):4-5. PubMed ID: 10971884
[No Abstract] [Full Text] [Related]
4. Gene patents, health care policy and licensing schemes.
Caulfield T; von Tigerstrom B
Trends Biotechnol; 2006 Jun; 24(6):251-4. PubMed ID: 16621074
[TBL] [Abstract][Full Text] [Related]
5. From eugenics to patents: genetics, law, and human rights.
Kevles DJ
Ann Hum Genet; 2011 May; 75(3):326-33. PubMed ID: 21488849
[No Abstract] [Full Text] [Related]
6. [No to patents for genetic diagnostics].
Lundsteen C
Ugeskr Laeger; 2000 Jun; 162(25):3620-1. PubMed ID: 11016292
[No Abstract] [Full Text] [Related]
7. Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics.
Aymé S; Matthijs G; Soini S;
Eur J Hum Genet; 2008 May; 16 Suppl 1():S10-9. PubMed ID: 18432281
[TBL] [Abstract][Full Text] [Related]
8. Patent or perish? An ethical approach to patenting human genes and proteins.
Macer DR
Pharmacogenomics J; 2002; 2(6):361-6. PubMed ID: 12629501
[No Abstract] [Full Text] [Related]
9. Introduction.
Matthijs G; Aymé S
Eur J Hum Genet; 2008 May; 16 Suppl 1():S1-2. PubMed ID: 18432280
[No Abstract] [Full Text] [Related]
10. Much ado about gene patents: the role of foreseeability.
Gulliford MJ
Seton Hall Law Rev; 2004; 34(2):711-45. PubMed ID: 15115032
[No Abstract] [Full Text] [Related]
11. Progress or peril? The ethical questions of human DNA mapping.
Belsie L
Christ Sci Monitor; 1999 Aug; ():15, 18. PubMed ID: 11648132
[No Abstract] [Full Text] [Related]
12. A modest proposal to amend the Patent Code 35 U.S.C. Section 287(c) to allow health care providers to examine their patients' DNA.
Minwalla S
South Ill Univ Law J; 2002; 26(3):471-504. PubMed ID: 16485364
[No Abstract] [Full Text] [Related]
13. [Diffuse rules on patent protection of genes. Scientists risk retroactive payment requirements].
Orn P
Lakartidningen; 2000 Nov; 97(46):5285-6. PubMed ID: 11116864
[No Abstract] [Full Text] [Related]
14. Genome patents.
Joly PB; de Looze MA; Mangematin V; Coronini R
Nature; 1996 Dec 19-26; 384(6610):608. PubMed ID: 8967946
[No Abstract] [Full Text] [Related]
15. China sets rules for foreign collaboration.
Hui L
Science; 1998 Sep; 281(5384):1779-80. PubMed ID: 9776675
[No Abstract] [Full Text] [Related]
16. Listening behind the questions--how experts can improve the public discourse on gene patenting.
Schulman M
Pharmacogenomics; 2003 Jul; 4(4):507-8. PubMed ID: 12831327
[No Abstract] [Full Text] [Related]
17. British MPs 'likely to oppose gene patents'.
Dickson D
Nature; 1995 Feb; 373(6515):550. PubMed ID: 7854400
[No Abstract] [Full Text] [Related]
18. Patents for what genes?
Nature; 1995 Apr; 374(6525):750. PubMed ID: 7723816
[No Abstract] [Full Text] [Related]
19. In pursuit of patents: 21st century challenges.
Blatt RJ
J Biolaw Bus; 1998; 1(4):4-7. PubMed ID: 11657745
[No Abstract] [Full Text] [Related]
20. Wrong map: why public science can't really be public.
Mukherjee S
New Repub; 2000 May; 222(19):14-5. PubMed ID: 12465651
[No Abstract] [Full Text] [Related]
[Next] [New Search]
